Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
DJS Law Group issued a solicitation notice announcing a class action lawsuit against Capricor Therapeutics on behalf of shareholders who purchased stock between December 17, 2025, and July 26, 2026. The complaint alleges the company made false statements regarding the statistical analysis plan for its drug Deramiocel and failed to secure FDA agreement prior to resubmitting its Biologics License Application.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.